Potassium Chloride Extended-release
- Product NDC
- 17856-1135
- 11-digit product format
- 178561135
- Labeler code
- 17856
- Product ID
- 17856-1135_4e41df31-dd11-84fa-e063-6394a90a8468
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Potassium Chloride Extended-release
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Atlantic Biologicals Corp.
- Application
- ANDA214452
- Marketing category
- ANDA
- Marketing start
- 2021-01-30
- Substance
- POTASSIUM CHLORIDE
- Active strength
- 1500 mg/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214452-001 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2020-10-21 | |
| A214452-002 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 20MEQ | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2020-10-21 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214452-001 | AB1 |
| A214452-002 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214452-001 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2020-10-21 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A214452-002 | POTASSIUM CHLORIDE | 20MEQ | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2020-10-21 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214452-001 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A214452-002 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | 2c407aaf-5d95-49ff-a5db-f1d7b5190334 | 2026-04-23 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Redpharm Drug | 37455920-e408-5906-e063-6294a90a57ae | 2026-04-15 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Atlantic Biologicals Corp. | 4d7ad5c6-2c18-dc29-e063-6394a90a621e | 2026-03-30 | Warnings, Adverse reactions | 214452 ANDA214452 17856-1135 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | ace1eb11-b925-405a-b772-58c60b3ca7d4 | 2025-12-03 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Granules India Ltd | 60285a8d-bcb0-40ba-b359-df5c89480cd6 | 2025-12-01 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride ER | POTASSIUM CHLORIDE ER | Direct_Rx | 42c92fcc-21d2-d32a-e063-6294a90a8312 | 2025-11-26 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Bluepoint Laboratories | d605ca36-2bfa-42cb-a46c-8ecb3162994e | 2025-11-10 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | A-S Medication Solutions | de335131-bb8a-44e5-89fa-1478edbcdc0e | 2025-11-06 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | A-S Medication Solutions | edb6c987-e2c3-421f-8a8d-849c9e17ace8 | 2025-11-06 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Granules Pharmaceuticals Inc. | b3d4d5b5-2898-ae3d-e053-2a95a90a6d04 | 2025-09-30 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Preferred Pharmaceuticals Inc. | 87f369cf-40e5-4f91-aa42-ae986fce6544 | 2025-09-10 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride ER | POTASSIUM CHLORIDE ER | Direct_Rx | 377854ff-8034-c7ac-e063-6294a90a0817 | 2025-06-13 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE EXTENDED-RELEASE | NCS HealthCare of KY, LLC dba Vangard Labs | c684758c-16f0-4bd9-b719-1aae64b7907f | 2025-01-16 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Proficient Rx LP | f191b15c-7959-4aa6-a2ef-617cde77c918 | 2024-10-01 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Bryant Ranch Prepack | b5505a39-57f1-4ed5-b845-4f1d8aa10950 | 2024-09-23 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Bryant Ranch Prepack | 7b8e7a4f-0d44-46b2-9565-7b4c294e9fcb | 2024-07-18 | Warnings, Adverse reactions | 214452 ANDA214452 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Proficient Rx LP | c53d1db5-1c9e-4289-a2a2-961e0dd56f32 | 2024-06-01 | Warnings, Adverse reactions | 214452 ANDA214452 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Potassium Chloride Extended-release
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| POTASSIUM CHLORIDE | 1500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 660YQ98I10 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1801294 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4d7ad5c6-2c18-dc29-e063-6394a90a621e | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1135-1 | Potassium Chloride Extended-release | 1 in 1 POUCH | TABLET, EXTENDED RELEASE | 1 | 2 | |
| 17856-1135-1 | Potassium Chloride Extended-release | 100 in 1 BOX, UNIT-DOSE | TABLET, EXTENDED RELEASE | 100 | 2 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1801294 | potassium chloride 20 MEQ Microencapsulated Extended Release Oral Tablet | PSN | 4d7ad5c6-2c18-dc29-e063-6394a90a621e | 2 |
| 1801294 | Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet | SCD | 4d7ad5c6-2c18-dc29-e063-6394a90a621e | 2 |
| 1801294 | Microencapsulated K+ Chloride 20 MEQ Extended Release Oral Tablet | SY | 4d7ad5c6-2c18-dc29-e063-6394a90a621e | 2 |
| 1801294 | Microencapsulated Pot Chloride 20 MEQ Extended Release Oral Tablet | SY | 4d7ad5c6-2c18-dc29-e063-6394a90a621e | 2 |
| 1801294 | potassium chloride 1500 MG Microencapsulated Extended Release Oral Tablet | SY | 4d7ad5c6-2c18-dc29-e063-6394a90a621e | 2 |
| 1801294 | potassium chloride 20 MEQ Microencapsulated Extended Release Oral Tablet | SY | 4d7ad5c6-2c18-dc29-e063-6394a90a621e | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 17856-1135-1 | 17856113501 | 100 POUCH in 1 BOX, UNIT-DOSE (17856-1135-1) / 1 TABLET, EXTENDED RELEASE in 1 POUCH | 100 pouch | 2021-01-30 | No | No | Current |